OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 11 citing articles:

Managing the Dual Nature of Iron to Preserve Health
Laura Silvestri, Mariateresa Pettinato, Valeria Furiosi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3995-3995
Open Access | Times Cited: 23

Soluble Hemojuvelin and Ferritin: Potential Prognostic Markers in Pediatric Hematopoietic Cell Transplantation
Jan Styczyński, Artur Słomka, Monika Łęcka, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1041-1041
Open Access | Times Cited: 12

The Impact of Iron on Cancer-Related Immune Functions in Oncology: Molecular Mechanisms and Clinical Evidence
Omar Badran, Idan Cohen, Gil Bar‐Sela
Cancers (2024) Vol. 16, Iss. 24, pp. 4156-4156
Open Access | Times Cited: 3

Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response
Antonio Di Grazia, Eleonora Franzè, Rachele Frascatani, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2

Enhanced CRC Growth in Iron-Rich Environment, Facts and Speculations
Marcello Chieppa, Marianna Kashyrina, Alessandro Miraglia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12389-12389
Open Access | Times Cited: 2

HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling
Vincenzo Formica, Silvia Riondino, Cristina Morelli, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 2, pp. 222-236
Closed Access | Times Cited: 5

Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line Treatment
Vincenzo Formica, Antonio Di Grazia, Maria Vittoria Bonomo, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3977-3977
Open Access | Times Cited: 1

Hepcidin: A multifaceted hormone in iron homeostasis and tumor biology
Xiaoyu Liu, Xinyu Zhang, Yumei Fan, et al.
Vitamins and hormones (2024)
Closed Access

Hepcidin Is a Valuable Therapeutic Target for Colorectal Cancer
Rachele Frascatani, Marco Colella, Giovanni Monteleone
Cancers (2024) Vol. 16, Iss. 23, pp. 4068-4068
Open Access

Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients
Katarzyna Wadowska, Piotr Błasiak, Adam Rzechonek, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 224-224
Open Access | Times Cited: 2

Multifaceted Insights into Innovative Approaches to Treating Colorectal Cancer Metastasis: From Emerging Biological Factors to Radiomics
Alessandro Ottaiano, Luisa Circelli, Mariachiara Santorsola, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4644-4644
Open Access

Page 1

Scroll to top